Heart Failure Pharmacology
Sort by:
Houston Methodist DeBakey Heart and Vascular Center
Medical Therapy in Advanced CHF: 2021 Guidelines & Study Reviews
FEATURING
Rayan Yousefzai
- 224 views
- May 27, 2021
Yale School of Medicine
ACC 21 Highlights: Angiotensin Receptor Neprilysin Inhibition Following Acute MI (PARADISE-MI) Trial
FEATURING
Rohan Khera
- 340 views
- June 14, 2021
- 1
Thomas Deering
Systolic Heart Failure: Autonomic Nervous System Considerations
- 707 views
- June 15, 2021
- 7
Georges Chahoud
Treating the HFrEF Patient: The Evolving Role of Angiotensin Receptor-Neprilysin Inhibitors
- 423 views
- June 23, 2021
- 4
Yale School of Medicine
Management of Heart Failure: Improving Quality of Care with EHR Technology
FEATURING
Katherine Clark
- 15 views
- July 13, 2021
Piedmont Heart Institute
Atrial Fibrillation Management in Systolic Heart Failure Patients: Rhythm Control vs. Rate Control
FEATURING
Sandeep Goyal,
Michael Hoosien
- 246 views
- July 13, 2021
- 1
Terumo Interventional Systems
Re-thinking Patient-Centered Care in Cardiology-Heart Failure Evaluation in Emergency Dept.
FEATURING
John Spertus
- 175 views
- July 14, 2021
- 1
Penn Medicine Heart and Vascular Center
Updates on the Diagnosis and Management of Amyloidosis
FEATURING
Brian Drachman
- 320 views
- August 16, 2021
- 4
Penn Medicine Heart and Vascular Center
Incorporating SGLT2 Inhibitors into Heart Failure Management
FEATURING
Monique Tanna,
Joyce Wald
- 176 views
- August 17, 2021
Houston Methodist DeBakey Heart and Vascular Center
Acute Heart Failure: What Is Optimal Medical Therapy?
FEATURING
Christopher O’Connor
- 793 views
- August 24, 2021
- 5
Scripps Health
2021 Update on HF Pharmacological Management: HF & Cardiac Amyloidosis Therapeutic Approaches and Clinical Trials Overview
FEATURING
Thomas Heywood
- 568 views
- August 25, 2021
- 5
Scripps Health
2021 Primary Care Clinical Trial Highlights: OSA Evals, Breast Cancer Prevention, Hep C Screening, AF and HFrEF
FEATURING
Joel C. Diamant
- 1,260 views
- August 26, 2021
- 5
CVRx | Barostim
Baroreflex Activation Therapy Overview of Clinical Data
FEATURING
Lana Tsao
- 548 views
- September 6, 2021
- 8
American Heart & Vascular Institute
Q&A: Understanding SGLT-2 Inhibitors in the CardioNephroEndo Space
- 505 views
- September 9, 2021
American Heart & Vascular Institute
Cardiovascular Updates for Healthcare Professionals: Team Sport of Initiating SGLT2i
FEATURING
Harold Bays
- 439 views
- September 9, 2021
- 4
American Heart & Vascular Institute
Heart Failure With Preserved Ejection Fraction: Is the New Paradigm Treatment Finally Here? Insights from the EMPEROR-Preserved Trial
FEATURING
Javed Butler
- 1,739 views
- September 9, 2021
- 12
American Heart & Vascular Institute
Heart Failure With Reduced Ejection Fraction: New Therapies on the Horizon
FEATURING
Nasrien Ibrahim
- 1,163 views
- September 16, 2021
- 9